JNJ
-
Biologics
Tissue Regeneration Systems to Collaborate with J&J, DePuy Synthes
Sarah Schmid Earlier this summer, Johnson & Johnson Innovation and DePuy Synthes Products announced a new collaboration with Plymouth, MI-based Tissue Regeneration Systems (TRS) to…
Read More » -
Uncategorized
Stryker settles hip implant suit against J&J’s DePuy
August 13, 2014 by Brad Perriello Stryker Corp. settles a patent infringement lawsuit filed against Johnson & Johnson’s DePuy Orthopaedics division; co-defendants…
Read More » -
Financial
More mega-merger talk from medtech giants
August 4, 2014 by Arezu Sarvestani Leadership at Johnson & Johnson and Teleflex weigh in on the multi-billion-dollar mergers that are shifting…
Read More » -
Biologics
Johnson & Johnson partners with Organovo to consider 3D-printing living tissue
The partnership centers around using bioprinted tissue to discover new drugs. The announcement comes ahead of Organovo’s commercial launch later…
Read More » -
Financial
Johnson & Johnson Board Approves Additional $5 Billion Stock Buyback
NEW BRUNSWICK, N.J., July 21, 2014 /PRNewswire/ — Johnson & Johnson (JNJ) today announced that its Board of Directors has approved…
Read More » -
Financial
J&J’s pharmaceutical prowess drives surging sales
by Laura Lorenzetti @lauralorenzetti Johnson & Johnson’s pharmaceutical business is thriving as its consumer and medical device units lag behind. Johnson &…
Read More » -
Financial
Johnson & Johnson escapes lawsuit over ex-CEO Weldon’s pay
June 26, 2014 by Brad Perriello A federal judge dismisses a lawsuit accusing Johnson & Johnson of over-paying former CEO William Weldon.…
Read More » -
Uncategorized
Medtronic a big user of tax havens, holding $20.5 billion overseas
Article by: JENNIFER BJORHUS , Star Tribune Medtronic Inc., famous for heart devices, also has a less-well-known distinction: It’s one of the…
Read More » -
Recon
Johnson & Johnson medical device presence growing in China
May 27, 2014 | By Joseph Keenan Not satisfied with being the world’s biggest health-care products company, Johnson & Johnson ($JNJ)…
Read More » -
Uncategorized
J&J’s pipeline include 30 ‘major’ medical devices and a surgical robot
May 22, 2014 by Brad Perriello Johnson & Johnson is planning to file for approval for 30 ‘major’ medical devices worldwide through…
Read More » -
Is J&J’s Forgotten Half About to Take Off?
Johnson & Johnson (NYSE: JNJ ) is often cited as the biggest pharmaceutical company in the world, but it also generates a…
Read More » -
Uncategorized
J&J/Synthes Merger Less than Half Complete
Johnson & Johnson (New Brunswick, NJ) faces some setbacks with its $21.3 billion acqusition of Synthes. According toFinanz und Wirtschaft, a…
Read More » -
Greek prosecutors bring corruption charges over state hospital deals with DePuy
Greek prosecutors bring corruption charges over state hospital deals with DePuy (FoxNews) Greek prosecutors have brought criminal corruption charges related to state hospitalpurchases from…
Read More » -
J&J’s Marketer E-Mailed Hip Safety Concerns Before Recall
A top marketing executive at Johnson & Johnson’s DePuy unit said the company should consider a recall of a hip implant…
Read More » -
Is Johnson & Johnson eyeing Edwards, St. Jude?
Johnson & Johnson, already the world’s largest health products maker, could have its eye on Edwards Lifesciences and St. Jude…
Read More »